These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Perioperative glycaemic control for people with diabetes undergoing surgery. Bellon F; Solà I; Gimenez-Perez G; Hernández M; Metzendorf MI; Rubinat E; Mauricio D Cochrane Database Syst Rev; 2023 Aug; 8(8):CD007315. PubMed ID: 37526194 [TBL] [Abstract][Full Text] [Related]
5. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus. Fullerton B; Jeitler K; Seitz M; Horvath K; Berghold A; Siebenhofer A Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD009122. PubMed ID: 24526393 [TBL] [Abstract][Full Text] [Related]
6. Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials. Hemmingsen B; Lund SS; Gluud C; Vaag A; Almdal T; Hemmingsen C; Wetterslev J BMJ; 2011 Nov; 343():d6898. PubMed ID: 22115901 [TBL] [Abstract][Full Text] [Related]
7. Targeting intensive versus conventional glycaemic control for type 1 diabetes mellitus: a systematic review with meta-analyses and trial sequential analyses of randomised clinical trials. Kähler P; Grevstad B; Almdal T; Gluud C; Wetterslev J; Lund SS; Vaag A; Hemmingsen B BMJ Open; 2014 Aug; 4(8):e004806. PubMed ID: 25138801 [TBL] [Abstract][Full Text] [Related]
8. Glucose targets for preventing diabetic kidney disease and its progression. Ruospo M; Saglimbene VM; Palmer SC; De Cosmo S; Pacilli A; Lamacchia O; Cignarelli M; Fioretto P; Vecchio M; Craig JC; Strippoli GF Cochrane Database Syst Rev; 2017 Jun; 6(6):CD010137. PubMed ID: 28594069 [TBL] [Abstract][Full Text] [Related]
9. Perioperative glycaemic control for diabetic patients undergoing surgery. Buchleitner AM; Martínez-Alonso M; Hernández M; Solà I; Mauricio D Cochrane Database Syst Rev; 2012 Sep; (9):CD007315. PubMed ID: 22972106 [TBL] [Abstract][Full Text] [Related]
10. Metformin and second- or third-generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus. Madsen KS; Kähler P; Kähler LKA; Madsbad S; Gnesin F; Metzendorf MI; Richter B; Hemmingsen B Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012368. PubMed ID: 30998259 [TBL] [Abstract][Full Text] [Related]
11. Effects of glucose-lowering and multifactorial interventions on cardiovascular and mortality outcomes: a meta-analysis of randomized control trials. Seidu S; Achana FA; Gray LJ; Davies MJ; Khunti K Diabet Med; 2016 Mar; 33(3):280-9. PubMed ID: 26282461 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials. Erpeldinger S; Rehman MB; Berkhout C; Pigache C; Zerbib Y; Regnault F; Guérin E; Supper I; Cornu C; Kassaï B; Gueyffier F; Boussageon R BMC Endocr Disord; 2016 Jul; 16(1):39. PubMed ID: 27391319 [TBL] [Abstract][Full Text] [Related]
13. Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia. Areosa Sastre A; Vernooij RW; González-Colaço Harmand M; Martínez G Cochrane Database Syst Rev; 2017 Jun; 6(6):CD003804. PubMed ID: 28617932 [TBL] [Abstract][Full Text] [Related]
14. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. Boussageon R; Bejan-Angoulvant T; Saadatian-Elahi M; Lafont S; Bergeonneau C; Kassaï B; Erpeldinger S; Wright JM; Gueyffier F; Cornu C BMJ; 2011 Jul; 343():d4169. PubMed ID: 21791495 [TBL] [Abstract][Full Text] [Related]